{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T09:37:25Z","timestamp":1793871445408,"version":"4.6.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR300273"],"award-info":[{"award-number":["NIHR300273"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N013700\/1"],"award-info":[{"award-number":["MR\/N013700\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/P006841\/1"],"award-info":[{"award-number":["MR\/P006841\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"JW is funded by a National Health and Medical Research Council (NHMRC) Postgraduate Research Scholarship.","id":[{"id":"https:\/\/ror.org\/011kf5r70","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1038\/s41386-020-0667-2","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T12:02:37Z","timestamp":1586347357000},"page":"1799-1806","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":269,"title":["Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2851-5252","authenticated-orcid":false,"given":"Edward","family":"Chesney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8920-3407","authenticated-orcid":false,"given":"Dominic","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simina","family":"Sovi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Englund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom P.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,8]]},"reference":[{"key":"667_CR1","doi-asserted-by":"publisher","first-page":"l5708","DOI":"10.1136\/bmj.l5708","volume":"366","author":"J Wise","year":"2019","unstructured":"Wise J. European drug agency approves cannabis-based medicine for severe forms of epilepsy. BMJ. 2019;366:l5708.","journal-title":"BMJ."},{"key":"667_CR2","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.2337\/dc16-0650","volume":"39","author":"KA Jadoon","year":"2016","unstructured":"Jadoon KA, Ratcliffe SH, Barrett DA, Thomas EL, Stott C, Bell JD, et al. Efficacy and safety of cannabidiol and tetrahydrocannabivarin on glycemic and lipid parameters in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel group pilot study. Diabetes Care. 2016;39:1777\u201386.","journal-title":"Diabetes Care."},{"key":"667_CR3","unstructured":"GW Research Ltd. Study to assess the effect of cannabidiol on liver fat levels in subjects with fatty liver disease. ClinicalTrialsGov; 2014. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01284634. Accessed 15 June 2019."},{"key":"667_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1176\/appi.ajp.2017.17030325","volume":"175","author":"P McGuire","year":"2018","unstructured":"McGuire P, Robson P, Cubala WJ, Vasile D, Morrison PD, Barron R, et al. Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial. Am J Psychiatry. 2018;175:225\u201331.","journal-title":"Am J Psychiatry"},{"key":"667_CR5","doi-asserted-by":"publisher","first-page":"l1141","DOI":"10.1136\/bmj.l1141","volume":"365","author":"TP Freeman","year":"2019","unstructured":"Freeman TP, Hindocha C, Green SF, Bloomfield MAP. Medicinal use of cannabis based products and cannabinoids. BMJ. 2019;365:l1141.","journal-title":"BMJ."},{"key":"667_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","volume":"153","author":"RG Pertwee","year":"2008","unstructured":"Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949\u2010tetrahydrocannabinol, cannabidiol and \u03949\u2010tetrahydrocannabivarin. Br J Pharmacol. 2008;153:199\u2013215.","journal-title":"Br J Pharmacol"},{"key":"667_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/j.1471-4159.2007.05073.x","volume":"104","author":"P Massi","year":"2008","unstructured":"Massi P, Valenti M, Vaccani A, Gasperi V, Perletti G, Marras E, et al. 5\u2010Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non\u2010psychoactive cannabinoid. J Neurochem. 2008;104:1091\u2013100.","journal-title":"J Neurochem"},{"key":"667_CR8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/bph.12944","volume":"172","author":"JM McPartland","year":"2015","unstructured":"McPartland JM, Duncan M, Di Marzo V, Pertwee RG. Are cannabidiol and \u03949-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. Br J Pharmacol. 2015;172:737\u201353.","journal-title":"Br J Pharmacol"},{"key":"667_CR9","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1098\/rstb.2011.0389","volume":"367","author":"AC Campos","year":"2012","unstructured":"Campos AC, Moreira FA, Gomes FV, Del Bel EA, Guimaraes FS. Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philos Trans R Soc B Biol Sci. 2012;367:3364\u201378.","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"667_CR10","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1111\/bph.13250","volume":"172","author":"RB Laprairie","year":"2015","unstructured":"Laprairie RB, Bagher AM, Kelly MEM, Denovan-Wright EM. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br J Pharmacol. 2015;172:4790\u2013805.","journal-title":"Br J Pharmacol"},{"key":"667_CR11","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3389\/fphar.2016.00422","volume":"7","author":"C Rohleder","year":"2016","unstructured":"Rohleder C, M\u00fcller JK, Lange B, Leweke FM. Cannabidiol as a potential new type of an antipsychotic. A critical review of the evidence. Front Pharmacol. 2016;7:422.","journal-title":"Front Pharmacol."},{"key":"667_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/can.2016.0034","volume":"2","author":"K Iffland","year":"2017","unstructured":"Iffland K, Grotenhermen F. An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies. Cannabis Cannabinoid Res. 2017;2:139\u201354.","journal-title":"Cannabis Cannabinoid Res"},{"key":"667_CR13","doi-asserted-by":"publisher","first-page":"974","DOI":"10.2174\/1570159X17666190603171901","volume":"17","author":"MA Huestis","year":"2019","unstructured":"Huestis MA, Solimini R, Pichini S, Pacifici R, Carlier J, Busard\u00f2 FP. Cannabidiol adverse effects and toxicity. Curr Neuropharmacol. 2019;17:974\u201389.","journal-title":"Curr Neuropharmacol."},{"key":"667_CR14","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1001\/jama.2015.6358","volume":"313","author":"PF Whiting","year":"2015","unstructured":"Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, et al. Cannabinoids for medical use a systematic review and meta-analysis. JAMA. 2015;313:2456.","journal-title":"JAMA."},{"key":"667_CR15","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s40265-018-0992-5","volume":"78","author":"S Lattanzi","year":"2018","unstructured":"Lattanzi S, Brigo F, Trinka E, Zaccara G, Cagnetti C, Del Giovane C, et al. Efficacy and safety of cannabidiol in epilepsy: a systematic review and meta-analysis. Drugs. 2018;78:1791\u2013804.","journal-title":"Drugs."},{"key":"667_CR16","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ."},{"key":"667_CR17","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","volume":"378","author":"O Devinsky","year":"2018","unstructured":"Devinsky O, Patel AD, Cross JH, Villanueva V, Wirrell EC, Privitera M, et al. Effect of cannabidiol on drop seizures in the Lennox\u2013Gastaut syndrome. N Engl J Med. 2018;378:1888\u201397.","journal-title":"N Engl J Med"},{"key":"667_CR18","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","volume":"376","author":"O Devinsky","year":"2017","unstructured":"Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, et al. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N. Engl J Med. 2017;376:2011\u201320.","journal-title":"N. Engl J Med"},{"key":"667_CR19","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00213-018-4885-9","volume":"235","author":"DL Boggs","year":"2018","unstructured":"Boggs DL, Surti T, Gupta A, Gupta S, Niciu M, Pittman B, et al. The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial. Psychopharmacology. 2018;235:1923\u201332.","journal-title":"Psychopharmacology"},{"key":"667_CR20","unstructured":"GW Research Ltd. A randomized controlled trial to investigate possible drug-drug interactions between clobazam and cannabidiol. ClinicalTrialsGov; 2018. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02565108. Accessed 15 June 2019."},{"key":"667_CR21","doi-asserted-by":"publisher","first-page":"e1204","DOI":"10.1212\/WNL.0000000000005254","volume":"90","author":"O Devinsky","year":"2018","unstructured":"Devinsky O, Patel AD, Thiele EA, Wong MH, Appleton R, Harden CL, et al. Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome. Neurology. 2018;90:e1204\u2013e1211.","journal-title":"Neurology."},{"key":"667_CR22","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","volume":"391","author":"EA Thiele","year":"2018","unstructured":"Thiele EA, Marsh ED, French JA, Mazurkiewicz-Beldzinska M, Benbadis SR, Joshi C, et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2018;391:1085\u201396.","journal-title":"Lancet."},{"key":"667_CR23","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","volume":"32","author":"L Taylor","year":"2018","unstructured":"Taylor L, Gidal B, Blakey G, Tayo B, Morrison G. A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects. CNS Drugs. 2018;32:1053\u201367.","journal-title":"CNS Drugs."},{"key":"667_CR24","unstructured":"Hill KP. Cannabidiol pharmacotherapy for adults with cannabis use disorder (NCT03102918). ClinicalTrialsGov; 2019."},{"key":"667_CR25","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s10620-017-4540-z","volume":"62","author":"T Naftali","year":"2017","unstructured":"Naftali T, Mechulam R, Marii A, Gabay G, Stein A, Bronshtain M, et al. Low-dose cannabidiol is safe but not effective in the treatment for Crohn\u2019s Disease, a randomized controlled trial. Dig Dis Sci. 2017;62:1615\u201320.","journal-title":"Dig Dis Sci"},{"key":"667_CR26","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/0091-3057(91)90386-G","volume":"40","author":"P Consroe","year":"1991","unstructured":"Consroe P, Laguna J, Allender J, Snider S, Stern L, Sandyk R, et al. Controlled clinical trial of cannabidiol in Huntington\u2019s disease. Pharmacol Biochem Behav. 1991;40:701\u20138.","journal-title":"Pharmacol Biochem Behav"},{"key":"667_CR27","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","volume":"391","author":"EA Thiele","year":"2018","unstructured":"Thiele EA, Marsh ED, French JA, Mazurkiewicz MB, Benbadis SR, Joshi C, et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2018;391:1085\u201396.","journal-title":"Lancet."},{"key":"667_CR28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/bcp.14028","volume":"86","author":"GJ Groeneveld","year":"2020","unstructured":"Groeneveld GJ, Martin JH. Parasitic pharmacology: a plausible mechanism of action for cannabidiol. Br J Clin Pharmacol. 2020;86:189\u201391.","journal-title":"Br J Clin Pharmacol"},{"key":"667_CR29","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.yebeh.2018.07.027","volume":"88","author":"KA Schoedel","year":"2018","unstructured":"Schoedel KA, Szeto I, Setnik B, Sellers EM, Levy-Cooperman N, Mills C, et al. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: a randomized, double-blind, controlled trial. Epilepsy Behav. 2018;88:162\u201371.","journal-title":"Epilepsy Behav."},{"key":"667_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/gps.5048","volume":"34","author":"G Sun","year":"2019","unstructured":"Sun G, Zhang L, Zhang L, Wu Z, Hu D. Benzodiazepines or related drugs and risk of pneumonia: A systematic review and meta-analysis. Int J Geriatr Psychiatry. 2019;34:513\u201321.","journal-title":"Int J Geriatr Psychiatry"},{"key":"667_CR31","unstructured":"FDA Centre for Drug Evaluation and Research. Drug approval package: epidiolex (Cannabidiol). Clin Rev. 2018:30."},{"key":"667_CR32","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/cpdd.665","volume":"8","author":"G Morrison","year":"2019","unstructured":"Morrison G, Crockett J, Blakey G, Sommerville K. A Phase 1, open\u2010label, pharmacokinetic trial to investigate possible drug\u2010drug interactions between clobazam, stiripentol, or valproate and cannabidiol in healthy subjects. Clin Pharmacol Drug Dev. 2019;8:1009\u201331.","journal-title":"Clin Pharmacol Drug Dev"},{"key":"667_CR33","unstructured":"FDA Centre for Drug Evaluation and Research. Drug approval package: epidiolex (cannabidiol). Summ Rev. 2018:30."},{"key":"667_CR34","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/gut.48.6.859","volume":"48","author":"RG Pertwee","year":"2001","unstructured":"Pertwee RG. Cannabinoids and the gastrointestinal tract. Gut. 2001;48:859\u201367.","journal-title":"Gut."},{"key":"667_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.neuropharm.2017.05.033","volume":"124","author":"BK Lau","year":"2017","unstructured":"Lau BK, Cota D, Cristino L, Borgland SL. Endocannabinoid modulation of homeostatic and non-homeostatic feeding circuits. Neuropharmacology. 2017;124:38\u201351.","journal-title":"Neuropharmacology."},{"key":"667_CR36","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1038\/npp.2010.58","volume":"35","author":"CJA Morgan","year":"2010","unstructured":"Morgan CJA, Freeman TP, Schafer GL, Curran HV. Cannabidiol attenuates the appetitive effects of \u03949- tetrahydrocannabinol in humans smoking their chosen cannabis. Neuropsychopharmacology. 2010;35:1879\u201385.","journal-title":"Neuropsychopharmacology."},{"key":"667_CR37","first-page":"CD006162","volume":"4","author":"C Curioni","year":"2006","unstructured":"Curioni C, Andr\u00e9 C. Rimonabant for overweight or obesity. Cochrane Database Syst Rev. 2006;4:CD006162.","journal-title":"Cochrane Database Syst Rev"},{"key":"667_CR38","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2147\/TCRM.S126849","volume":"14","author":"ME Badowski","year":"2018","unstructured":"Badowski ME, Yanful PK. Dronabinol oral solution in the management of anorexia and weight loss in AIDS and cancer. Ther Clin Risk Manag. 2018;14:643\u201351.","journal-title":"Ther Clin Risk Manag"},{"key":"667_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/eat.22173","volume":"47","author":"A Andries","year":"2014","unstructured":"Andries A, Frystyk J, Flyvbjerg A, St\u00f8ving RK. Dronabinol in severe, enduring anorexia nervosa: a randomized controlled trial. Int J Eat Disord. 2014;47:18\u201323.","journal-title":"Int J Eat Disord"},{"key":"667_CR40","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1001\/jama.2017.11909","volume":"318","author":"MO Bonn-Miller","year":"2017","unstructured":"Bonn-Miller MO, Loflin MJE, Thomas BF, Marcu JP, Hyke T, Vandrey R. Labeling accuracy of cannabidiol extracts sold online. JAMA. 2017;318:1708\u20139.","journal-title":"JAMA."},{"key":"667_CR41","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1016\/j.forsciint.2018.10.019","volume":"294","author":"JL Poklis","year":"2019","unstructured":"Poklis JL, Mulder HA, Peace MR. The unexpected identification of the cannabimimetic, 5F-ADB, and dextromethorphan in commercially available cannabidiol e-liquids. Forensic Sci Int. 2019;294:e25\u2013e27.","journal-title":"Forensic Sci Int"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41386-020-0667-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-020-0667-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-020-0667-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:08:46Z","timestamp":1684602526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-020-0667-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,8]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["667"],"URL":"https:\/\/doi.org\/10.1038\/s41386-020-0667-2","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,8]]},"assertion":[{"value":"8 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}